Chemotherapy in Advanced Breast Carcinoma Comparison Between Doxorubicin-Cyclophosphamide and Cyclophosphamide-Methotrex-Ate-5-Fluorouracil-Vincristine-Prednisone
- 1 January 1985
- journal article
- research article
- Published by Taylor & Francis in Acta Radiologica: Oncology
- Vol. 24 (5) , 391-394
- https://doi.org/10.3109/02841868509134406
Abstract
Two chemotherapeutic regimens were compared in 102 patients with metastatic brest carcinoma, randomized to either doxorubicin-cyclophosphamide (DC) or cyclophosphamide-methotrexate-5-fluorouracil-vincristine-prednisone (CMFVP). The objective response rates were 32 per cent in the former and 35 per cent in the latter group, the complete response rates 6.4 and 21.8 per cent, and mean duration of the remission 7.7 and 11.2 months, respectively. Most responders had multiple metastases and had received previous hormonal treatment. The DC regimen was found to be slightly more toxic than CMFVP.This publication has 9 references indexed in Scilit:
- Chemotherapy of advanced breast cancer a general surveyCancer, 1984
- Comparison of induction chemotherapies for metastatic breast cancer. An eastern cooperative oncology group trialCancer, 1982
- Comparison of four-combination chemotherapy programs in metastatic breast cancer. Comparison of multiple drug therapy with cytoxan, 5-fu and prednisone versus cytoxan and adriamycin, versus cytoxan, 5-Fu and adriamycin, versus cytoxan, 5-Fu and prednisone alternating with cytoxan and adriamycinCancer, 1982
- Adriamycin combinations in advanced breast cancer:A southwest oncology group studyCancer, 1982
- Prognostic Factors in the Initial Response to Therapy by Patients With Advanced Breast Cancer 2JNCI Journal of the National Cancer Institute, 1978
- A comparison of cyclophosphamide, adriamycin, 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, prednisone (CMFVP) in patients with metastatic breast cancer.A southeastern cancer study group projectCancer, 1977
- Combination chemotherapy and adriamycin in patients with advanced breast cancer.A Southwest Oncology Group studyCancer, 1976
- Combination chemotherapy with adriamycin and cyclophosphamide for advanced breast cancerCancer, 1975
- Single and combination nonhormonal chemotherapy in breast cancerCancer, 1972